1-2 of 2
Keywords: sulphaphenazole
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

To b'EET or not to b'EET? That is the question!

Amrita AHLUWALIA
Journal: Clinical Science
Clin Sci (Lond) (2003) 105 (4): 399–401.
https://doi.org/10.1042/CS20030232
Published: 01 October 2003
... is not a candidate for a ubiquitous EDHF. 10 7 2003 1 8 2003 1 8 2003 © 2003 The Biochemical Society 2003 bradykinin cytochrome P450 endothelium-derived hyperpolarizing factor forearm sulphaphenazole vasodilation Clinical Science (2003) 105, 399 401 (Printed in Great Britain) 399...
View article titled, To b'EET or not to b'EET? That is the question!
Open the PDF for To b'EET or not to b'EET? That is the question! in another window
Articles

Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazole

Jens PASSAUER, Eckhart BÜSSEMAKER, Grit LÄSSIG, Frank PISTROSCH, Joachim FAULER, Peter GROSS, Ingrid FLEMING
Journal: Clinical Science
Clin Sci (Lond) (2003) 105 (4): 513–518.
https://doi.org/10.1042/CS20030118
Published: 01 October 2003
.... The cytochrome P450 (CYP) 2C9 inhibitor sulphaphenazole was recently identified as a potent inhibitor of NO- and prostacyclin (PGI 2 )-independent relaxation in porcine coronary arteries. The aim of the present study was to determine the effect of sulphaphenazole on basal and bradykinin-induced NO/PGI 2...
View article titled, Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor <span class="search-highlight">sulphaphenazole</span>
Open the PDF for Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor <span class="search-highlight">sulphaphenazole</span> in another window